-
Je něco špatně v tomto záznamu ?
Prognostic significance of ischemia modified albumin after percutaneous coronary intervention
Dusek J, St'ásek J, Tichý M, Bis J, Gregor J, Vojácek J, Masín V, Polanský P, Brtko M, Cernohorský D.
Jazyk angličtina Země Nizozemsko
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- albuminy metabolismus MeSH
- balónková koronární angioplastika MeSH
- financování organizované MeSH
- ischemie diagnóza krev metabolismus terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- patologická angiogeneze krev patologie MeSH
- prognóza MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
Ischemia modified albumin (IMA) is a new biochemical marker of ischemia. IMA levels rise in patients who develop ischemia during percutaneous coronary intervention (PCI). It is unclear whether IMA elevations correlate with PCI variables. The possible prognostic value of post-PCI IMA elevation has not yet to be studied. METHODS: We studied 60 patients (mean age 61 years; 51 male) who underwent successful elective single-vessel PCI for the management of stable angina pectoris. IMA levels were measured and compared with PCI variables and target lesion revascularization rate. The median post-PCI follow up is 46 months (CI 44.6 to 47.7). RESULTS: We found that the only variable related to post-PCI IMA levels was periprocedural dissection of target vessel (147.6 vs. 141.1 kU/l, p=0.035). No correlation between high and low balloon inflation pressure (143.6 vs. 141.6 kU/l, p=0.64), short and long inflation pressure (141.5 vs. 143.6 kU/l, p=0.17), with and without stent placement (143.7 vs. 141.3 kU/l, p=0.93) was found. IMA level more then 130 kU/l was associated with higher frequency of target lesion revascularization at nearly 4-years follow-up (p=0.026). CONCLUSION: Post-PCI IMA elevation is associated with higher target lesion revascularization.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07521923
- 003
- CZ-PrNML
- 005
- 20111210133028.0
- 008
- 090423s2006 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Dušek, Jaroslav. $7 xx0190321
- 245 10
- $a Prognostic significance of ischemia modified albumin after percutaneous coronary intervention / $c Dusek J, St'ásek J, Tichý M, Bis J, Gregor J, Vojácek J, Masín V, Polanský P, Brtko M, Cernohorský D.
- 314 __
- $a First Department of Internal Medicine, University Hospital Hradec Králové, Czech Republic. dusek@fnhk.cz
- 520 9_
- $a Ischemia modified albumin (IMA) is a new biochemical marker of ischemia. IMA levels rise in patients who develop ischemia during percutaneous coronary intervention (PCI). It is unclear whether IMA elevations correlate with PCI variables. The possible prognostic value of post-PCI IMA elevation has not yet to be studied. METHODS: We studied 60 patients (mean age 61 years; 51 male) who underwent successful elective single-vessel PCI for the management of stable angina pectoris. IMA levels were measured and compared with PCI variables and target lesion revascularization rate. The median post-PCI follow up is 46 months (CI 44.6 to 47.7). RESULTS: We found that the only variable related to post-PCI IMA levels was periprocedural dissection of target vessel (147.6 vs. 141.1 kU/l, p=0.035). No correlation between high and low balloon inflation pressure (143.6 vs. 141.6 kU/l, p=0.64), short and long inflation pressure (141.5 vs. 143.6 kU/l, p=0.17), with and without stent placement (143.7 vs. 141.3 kU/l, p=0.93) was found. IMA level more then 130 kU/l was associated with higher frequency of target lesion revascularization at nearly 4-years follow-up (p=0.026). CONCLUSION: Post-PCI IMA elevation is associated with higher target lesion revascularization.
- 650 _2
- $a albuminy $x metabolismus $7 D000418
- 650 _2
- $a balónková koronární angioplastika $7 D015906
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ischemie $x diagnóza $x krev $x metabolismus $x terapie $7 D007511
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a patologická angiogeneze $x krev $x patologie $7 D009389
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Šťásek, Josef, $d 1955- $7 xx0063485
- 700 1_
- $a Tichý, Miloš, $d 1941- $7 xx0112487
- 700 1_
- $a Bis, Josef $7 xx0071045
- 700 1_
- $a Gregor, Jaroslav $7 xx0081909
- 700 1_
- $a Vojáček, Jan, $d 1947- $7 jn20000402578
- 700 1_
- $a Mašín, Vladimír $7 xx0061146
- 700 1_
- $a Polanský, Pavel $7 xx0101818
- 700 1_
- $a Brtko, Miroslav $7 xx0035884
- 700 1_
- $a Černohorský, Dušan $7 xx0101390
- 773 0_
- $w MED00009464 $t Clinica chimica acta $g Roč. 367, č. 1-2 (2006), s. 77-80 $x 0009-8981
- 910 __
- $a ABA008 $b A 2555 $y 9
- 990 __
- $a 20090312170439 $b ABA008
- 991 __
- $a 20111018143753 $b ABA008
- 999 __
- $a ok $b bmc $g 645012 $s 497928
- BAS __
- $a 3
- BMC __
- $a 2006 $b 367 $c 1-2 $d 77-80 $i 0009-8981 $m Clinica chimica acta $x MED00009464
- LZP __
- $a 2009-B1/vtme